Cover Image

Omalizumab in treatment-resistant chronic spontaneous urticaria

Saved in:

Bibliographic Details
Main Author:	Kiran V Godse (Author)
Format:	Book
Published:	Wolters Kluwer Medknow Publications, 2011-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Profile of omalizumab in the treatment of chronic spontaneous urticaria
by: Labrador-Horrillo M, et al.
Published: (2015)

Position statement for the use of omalizumab in the management of chronic spontaneous urticaria in Indian patients
by: Kiran Godse, et al.
Published: (2016)

Alopecia Areata after Omalizumab Treatment for Chronic Spontaneous Urticaria
by: Eli Magen
Published: (2019)

Ebastine in chronic spontaneous urticaria in higher doses
by: Kiran V Godse
Published: (2011)

Omalizumab and new therapeutic targets in chronic spontaneous urticaria
by: Ana S. Pereira, et al.
Published: (2024)

Omalizumab in the treatment of chronic spontaneous urticaria - literature review and own experience
by: Joanna Dawicka, et al.
Published: (2016)

Clinical observation of desloratadine combined with omalizumab in the treatment of chronic spontaneous urticaria
by: Zhiwei SHANG, et al.
Published: (2022)

Retrospective analysis of the treatment of 61 cases of chronic spontaneous urticaria with omalizumab
by: Shanshan OU, et al.
Published: (2023)

Efficacy of omalizumab treatment for patients with chronic idiopathic urticaria (CIU)/chronic spontaneous urticaria (CSU) in Taiwan
by: Che-Wen Yang, et al.
Published: (2017)

Long-Term Omalizumab Use, Chronic Spontaneous Urticaria and COVID-19
by: Öner Özdemir
Published: (2024)

Omalizumab for the treatment of chronic spontaneous urticaria: association between body mass index and outcome
by: Irene Russo, et al.
Published: (2022)

Efficacy of Omalizumab Treatment with Concomitant Antihistamines as Needed for Moderate, Refractory Chronic Spontaneous Urticaria
by: Eustachio Nettis, et al.
Published: (2018)

Changes of Gut Microbiome in Adolescent Patients with Chronic Spontaneous Urticaria After Omalizumab Treatment
by: Wang M, et al.
Published: (2023)

PK/PD modeling to characterize placebo and treatment effect of omalizumab for chronic spontaneous urticaria
by: Elise Oh, et al.
Published: (2023)

Fexofenadine in higher doses in chronic spontaneous urticaria
by: Kiran V Godse, et al.
Published: (2010)

Rapid response of omalizumab-resistant chronic urticaria to acalabrutinib
by: Diamond R. Guy, BS, et al.
Published: (2024)

Chronic urticaria and treatment options
by: Godse Kiran
Published: (2009)

Omalizumab for Patients with Chronic Spontaneous Urticaria: A Narrative Review of Current Status
by: Thomas B. Casale, et al.
Published: (2023)

Position of omalizumab therapy in the treatment of spontaneous chronic urticaria. A case series and literature review
by: Aleksander Obtułowicz, et al.
Published: (2022)

Treatment of chronic spontaneous urticaria with a single dose of omalizumab: A study of four cases
by: Radhakrishnan Subramaniyan, et al.
Published: (2016)

Subcutaneous autologous serum therapy in chronic spontaneous urticaria
by: Kiran Vasant Godse, et al.
Published: (2017)

COVID-19 infection in chronic spontaneous urticaria treated with omalizumab: two case reports
by: Angelo Massimiliano D'Erme, et al.
Published: (2023)

Omalizumab in Chronic Spontaneous Urticaria: A Real-World Study on Effectiveness, Safety and Predictors of Treatment Outcome
by: Chen J, et al.
Published: (2024)

Omalizumab versus cyclosporin-A for the treatment of chronic spontaneous urticaria: can we define better-responding endotypes?
by: Emek Kocatürk, et al.
Published: (2022)

Clinical Response to Low-dose Omalizumab Treatment in Chronic Spontaneous Urticaria: A Retrospective Study of 179 Patients
by: Min Jae Kim, et al.
Published: (2023)

Complete response to dupilumab in a patient with chronic spontaneous urticaria who did not tolerate omalizumab
by: Changhua Zhu, MD, et al.
Published: (2023)

Cytokine Profiles of Chronic Urticaria Patients and the Effects of Omalizumab Treatment
by: Ozge Can Bostan, et al.
Published: (2023)

Treatment of chronic urticaria with omalizumab: the experience of Hospital de Braga
by: Ana G. Lopes, et al.
Published: (2022)

Omalizumab for treatment of chronic urticaria: A review of effective dose
by: javad Ghaffari, et al.
Published: (2019)

Olopatadine in chronic idiopathic urticaria
by: Godse Kiran
Published: (2009)

Patch testing in chronic urticaria
by: Godse Kiran
Published: (2009)

Long-term Omalizumab Therapy in Patients with Chronic Spontaneous Urticaria: Does it Increase the Risk of COVID-19?
by: Özge Kaya, et al.
Published: (2023)

The use of an urticaria control test for the evaluation of omalizumab treatment response in patients diagnosed with chronic urticaria
by: Burhan Engin, et al.
Published: (2020)

Predicting Response to Omalizumab in Chronic Urticaria Based on Biomarkers
by: Misbah Noshela Ghazanfar, et al.
Published: (2018)

Incapacitating solar urticaria: successful treatment with omalizumab
by: Katarina Kieselova, et al.
Published: (2019)

Treatment of refractory chronic urticaria
by: Aayushi Mehta, et al.
Published: (2015)

Omalizumab for chronic spontaneous urticaria in “complex” patients: data from real-life clinical practice
by: Vollono L, et al.
Published: (2019)

An Open-Label, Investigator-Initiated, Single-Centre Pilot Study to Determine the Safety and Efficacy of Tofacitinib in Resistant Chronic Spontaneous Urticaria
by: Abhishek De, et al.
Published: (2024)

Omalizumab for Chronic Urticaria: A Case Series and Overview of the Literature
by: Ilya Ivyanskiy, et al.
Published: (2012)

Omalizumab Use in Chronic Spontaneous Urticaria during Pregnancy and a Four Years' Follow-Up: A Case Report
by: Laura Michelina Losappio, et al.
Published: (2020)